A Multi-Center Biologics Registry and Biorepository of Platelet Rich Plasma for the Treatment of Symptomatic Knee Osteoarthritis Among Civilian and Military Populations

This study aims to evaluate outcomes of biologic therapies such as platelet-rich plasma (PRP) for common musculoskeletal conditions by leveraging the MOTION database and participating in the national Biologic Association Registry and Biorepository (BARB). It will collect and analyze patient-reported outcomes and return-to-service timelines, comparing biologic treatments to surgical outcomes across multiple sites.